TETeva TEVA · NYSE
$41.12 +0.98% (+$0.40)
- Market cap
- $47.5B
- Enterprise value
- $60.7B
- P/E
- 67.3x
- Forward P/E
- 19.8x
- PEG
- -
- P/S
- 2.7x
- P/FCF
- 35.2x
- EV/EBITDA
- 23.4x
- ROIC
- 6.8%
- Bruto marža
- 52.5%
- Neto marža
- 4.1%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 5.1x
- Beta
- 0.82
- Free float
- 99.8%
O podjetju
Teva Pharmaceutical Industries (TEVA) is an Israeli pharmaceutical company specializing in the development, production, and distribution of generic drugs and specialty pharmaceutical products. With a broad portfolio of generic medicines and proprietary products in areas such as neurology, oncology, and respiratory diseases, Teva is one of the largest producers of generic drugs in the world. The company is known for its ability to provide affordable medications and innovative treatment options for patients worldwide. Teva also invests in the research and development of new pharmaceuticals and biologics. Teva Pharmaceutical Industries (TEVA) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on generic drugs and specialty treatments.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
32,008
Headquarters
Tel Aviv
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke